Our STAT Op-Ed: Drug Importation Can’t Coexist with U.S. Track-and-Trace Law — DrugChannels.net
State drug importation laws undermine the process that keeps our supply chain safe
California Designated Representative Training Courses (for wholesaler, 3PL, reverse distributor). Largest selection of Board-approved California Designated Representative online training courses. Earns a training affidavit accepted by the California State Board of Pharmacy.
Read the full text of the Op-Ed: Our STAT Op-Ed: Drug Importation Can’t Coexist with U.S. Track-and-Trace Law — DrugChannels.net
From the Op-Ed:
“As we see it, there is no legal or operational way of transforming a drug packaged for a foreign market into a drug that meets the U.S. requirements of our in-progress track-and-trace system. What’s more, there is no way to alter the law to enable importation without undermining the law’s purpose and value. …
Importation laws undermine the country’s progress in building a modern technology infrastructure to track and trace prescription drugs. Making exceptions to the in-progress track-and-trace system would ignore the many instances of drug diversion and counterfeiting that led to the creation and passage of the law in 2013.”
The Op-Ed covers the following areas:
- State drug importation laws undermine the process that keeps our supply chain safe
- Why the U.S. is building a track-and-trace system
- How track-and-trace works
- Importation undermines the track-and-trace system
- Importation enables counterfeits
- Forgetting the lessons
. . .
Originally published at https://dreusa.blogspot.com/2019/07/our-stat-op-ed-drug-importation-cant.html